Phase I Study of Cabazitaxel, Mitoxantrone, and Prednisone (CAMP) for Patients With Metastatic Castration-Resistant Prostate Cancer and no Prior Chemotherapy

This study is currently recruiting participants.
Verified December 2013 by University of California, San Francisco
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Eric Small, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01594918
First received: May 7, 2012
Last updated: December 19, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)